hs683 human glioma cell line (Procell Inc)
Structured Review

Hs683 Human Glioma Cell Line, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hs683+human+glioma+cell+line/pmc11208487-90-1-10?v=Procell+Inc
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Stemness subtypes in lower-grade glioma with prognostic biomarkers, tumor microenvironment, and treatment response"
Article Title: Stemness subtypes in lower-grade glioma with prognostic biomarkers, tumor microenvironment, and treatment response
Journal: Scientific Reports
doi: 10.1038/s41598-024-65717-7
Figure Legend Snippet: ( A ) The qRT-PCR assays validated the siRNA knockdown effect. ( B ) The results of CCK-8 assay in HS683 cell lines. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; ns, no significance.
Techniques Used: Quantitative RT-PCR, Knockdown, CCK-8 Assay
Figure Legend Snippet: Scratch wound healing assessment of HS683 cell lines following treatment with siRNA or negative control (NC) targeting four hub genes: ( A ) CDCA8, ( B ) DLGAP5, ( C ) ORC1 and ( D ) SMC4. Transwell examination of LGG cell lines treated with siRNA or negative control (NC) to target four hub genes: ( E ) CDCA8, ( F ) DLGAP5, ( G ) ORC1 and ( H ) SMC4. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; ns, no significance.
Techniques Used: Negative Control
Figure Legend Snippet: The results of CCK-8 assay in HS683 cell lines. ( A ) SMC4, ( B ) DLGAP5, CDCA8 and ( D ) ORC1. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; ns, no significance.
Techniques Used: CCK-8 Assay
